Cargando…

RNA immunoprecipitation identifies novel targets of DAZL in human foetal ovary

STUDY QUESTION: Can novel meiotic RNA targets of DAZL (deleted in azoospermia-like) be identified in the human foetal ovary? SUMMARY ANSWER: SYCP1 (synaptonemal complex protein-1), TEX11 (testis expressed 11) and SMC1B (structural maintenance of chromosomes 1B) are novel DAZL targets in the human fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosario, Roseanne, Smith, Richard W.P., Adams, Ian R., Anderson, Richard A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5943682/
https://www.ncbi.nlm.nih.gov/pubmed/28364521
http://dx.doi.org/10.1093/molehr/gax004
_version_ 1783321676605292544
author Rosario, Roseanne
Smith, Richard W.P.
Adams, Ian R.
Anderson, Richard A.
author_facet Rosario, Roseanne
Smith, Richard W.P.
Adams, Ian R.
Anderson, Richard A.
author_sort Rosario, Roseanne
collection PubMed
description STUDY QUESTION: Can novel meiotic RNA targets of DAZL (deleted in azoospermia-like) be identified in the human foetal ovary? SUMMARY ANSWER: SYCP1 (synaptonemal complex protein-1), TEX11 (testis expressed 11) and SMC1B (structural maintenance of chromosomes 1B) are novel DAZL targets in the human foetal ovary, thus DAZL may have previously unrecognised roles in the translational regulation of RNAs involved in chromosome cohesion and DNA recombination in the oocyte from the time of initiation of meiosis. WHAT IS KNOWN ALREADY: The phenotype of Dazl deficiency in mouse is infertility in both sexes and DAZL has also been linked to infertility in humans. Few studies have explored targets of this RNA-binding protein. The majority of these investigations have been carried out in mouse, and have focussed on the male thus the basis for its central function in regulating female fertility is largely unknown. STUDY DESIGN SIZE, DURATION: We carried out RNA sequencing after immunoprecipitation of endogenous DAZL from human foetal ovarian tissue (17 weeks of gestation, obtained after elective termination of pregnancy) to identify novel DAZL targets involved in meiosis (n = 3 biological replicates). PARTICIPANTS/MATERIALS, SETTING, METHODS: Using quantitative RT-PCR, we examined the expression of selected RNAs identified by our immunoprecipitation across gestation, and visualised the expression of potential target SMC1B in relation to DAZL, with a combination of in situ hybridisation and immunohistochemistry. 3′ untranslated region (3′UTR)-luciferase reporter assays and polysome profile analysis were used to investigate the regulation of three RNA targets by DAZL, representing key functionalities: SYCP1, TEX11 and SMC1B. MAIN RESULTS AND THE ROLE OF CHANCE: We identified 764 potential RNA targets of DAZL in the human foetal ovary (false discovery rate 0.05 and log-fold change ≥ 2), with functions in synaptonemal complex formation (SYCP1, SYCP3), cohesin formation (SMC1B, RAD21), spindle assembly checkpoint (MAD2L1, TRIP13) and recombination and DNA repair (HORMAD1, TRIP13, TEX11, RAD18, RAD51). We demonstrated that the translation of novel targets SYCP1 (P = 0.004), TEX11 (P = 0.004) and SMC1B (P = 0.002) is stimulated by the presence of DAZL but not by a mutant DAZL with impaired RNA-binding activity. LARGE SCALE DATA: The raw data are available at GEO using the study ID: GSE81524. LIMITATIONS, REASONS FOR CAUTION: This analysis is based on identification of DAZL targets at the time when meiosis starts in the ovary: it may have other targets at other stages of oocyte development, and in the testis. Representative targets were validated, but detailed analysis was not performed on the majority of putative targets. WIDER IMPLICATIONS OF THE FINDINGS: These data indicate roles for DAZL in the regulation of several key functions in human oocytes. Through the translational regulation of novel RNA targets SMC1B and TEX11, DAZL may have a key role in regulating chromosome cohesion and DNA recombination; two processes fundamental in determining oocyte quality and whose establishment in foetal life may support lifelong fertility. STUDY FUNDING AND COMPETING INTEREST(S): This study was supported by the UK Medical Research Council (grant no G1100357 to R.A.A. and an intramural MRC programme grant to I.R.A.). The authors declare no competing interests.
format Online
Article
Text
id pubmed-5943682
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-59436822018-05-14 RNA immunoprecipitation identifies novel targets of DAZL in human foetal ovary Rosario, Roseanne Smith, Richard W.P. Adams, Ian R. Anderson, Richard A. Mol Hum Reprod Original Research STUDY QUESTION: Can novel meiotic RNA targets of DAZL (deleted in azoospermia-like) be identified in the human foetal ovary? SUMMARY ANSWER: SYCP1 (synaptonemal complex protein-1), TEX11 (testis expressed 11) and SMC1B (structural maintenance of chromosomes 1B) are novel DAZL targets in the human foetal ovary, thus DAZL may have previously unrecognised roles in the translational regulation of RNAs involved in chromosome cohesion and DNA recombination in the oocyte from the time of initiation of meiosis. WHAT IS KNOWN ALREADY: The phenotype of Dazl deficiency in mouse is infertility in both sexes and DAZL has also been linked to infertility in humans. Few studies have explored targets of this RNA-binding protein. The majority of these investigations have been carried out in mouse, and have focussed on the male thus the basis for its central function in regulating female fertility is largely unknown. STUDY DESIGN SIZE, DURATION: We carried out RNA sequencing after immunoprecipitation of endogenous DAZL from human foetal ovarian tissue (17 weeks of gestation, obtained after elective termination of pregnancy) to identify novel DAZL targets involved in meiosis (n = 3 biological replicates). PARTICIPANTS/MATERIALS, SETTING, METHODS: Using quantitative RT-PCR, we examined the expression of selected RNAs identified by our immunoprecipitation across gestation, and visualised the expression of potential target SMC1B in relation to DAZL, with a combination of in situ hybridisation and immunohistochemistry. 3′ untranslated region (3′UTR)-luciferase reporter assays and polysome profile analysis were used to investigate the regulation of three RNA targets by DAZL, representing key functionalities: SYCP1, TEX11 and SMC1B. MAIN RESULTS AND THE ROLE OF CHANCE: We identified 764 potential RNA targets of DAZL in the human foetal ovary (false discovery rate 0.05 and log-fold change ≥ 2), with functions in synaptonemal complex formation (SYCP1, SYCP3), cohesin formation (SMC1B, RAD21), spindle assembly checkpoint (MAD2L1, TRIP13) and recombination and DNA repair (HORMAD1, TRIP13, TEX11, RAD18, RAD51). We demonstrated that the translation of novel targets SYCP1 (P = 0.004), TEX11 (P = 0.004) and SMC1B (P = 0.002) is stimulated by the presence of DAZL but not by a mutant DAZL with impaired RNA-binding activity. LARGE SCALE DATA: The raw data are available at GEO using the study ID: GSE81524. LIMITATIONS, REASONS FOR CAUTION: This analysis is based on identification of DAZL targets at the time when meiosis starts in the ovary: it may have other targets at other stages of oocyte development, and in the testis. Representative targets were validated, but detailed analysis was not performed on the majority of putative targets. WIDER IMPLICATIONS OF THE FINDINGS: These data indicate roles for DAZL in the regulation of several key functions in human oocytes. Through the translational regulation of novel RNA targets SMC1B and TEX11, DAZL may have a key role in regulating chromosome cohesion and DNA recombination; two processes fundamental in determining oocyte quality and whose establishment in foetal life may support lifelong fertility. STUDY FUNDING AND COMPETING INTEREST(S): This study was supported by the UK Medical Research Council (grant no G1100357 to R.A.A. and an intramural MRC programme grant to I.R.A.). The authors declare no competing interests. Oxford University Press 2017-03 2017-02-18 /pmc/articles/PMC5943682/ /pubmed/28364521 http://dx.doi.org/10.1093/molehr/gax004 Text en © The Author 2017. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Original Research
Rosario, Roseanne
Smith, Richard W.P.
Adams, Ian R.
Anderson, Richard A.
RNA immunoprecipitation identifies novel targets of DAZL in human foetal ovary
title RNA immunoprecipitation identifies novel targets of DAZL in human foetal ovary
title_full RNA immunoprecipitation identifies novel targets of DAZL in human foetal ovary
title_fullStr RNA immunoprecipitation identifies novel targets of DAZL in human foetal ovary
title_full_unstemmed RNA immunoprecipitation identifies novel targets of DAZL in human foetal ovary
title_short RNA immunoprecipitation identifies novel targets of DAZL in human foetal ovary
title_sort rna immunoprecipitation identifies novel targets of dazl in human foetal ovary
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5943682/
https://www.ncbi.nlm.nih.gov/pubmed/28364521
http://dx.doi.org/10.1093/molehr/gax004
work_keys_str_mv AT rosarioroseanne rnaimmunoprecipitationidentifiesnoveltargetsofdazlinhumanfoetalovary
AT smithrichardwp rnaimmunoprecipitationidentifiesnoveltargetsofdazlinhumanfoetalovary
AT adamsianr rnaimmunoprecipitationidentifiesnoveltargetsofdazlinhumanfoetalovary
AT andersonricharda rnaimmunoprecipitationidentifiesnoveltargetsofdazlinhumanfoetalovary